The 20 Best Venous Thromboembolism (VTE) Doctors near Baltimore, MD

Elliott Haut is a General Surgeon in Baltimore, Maryland. Dr. Haut is rated as an Elite provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Low Blood Pressure, Hernia Surgery, and Appendectomy.

Michael Streiff is a Hematologist in Baltimore, Maryland. Dr. Streiff is rated as an Elite provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Sickle Cell Disease, Hemolytic Anemia, Hemoglobinopathy, and Congenital Hemolytic Anemia.

Dr. Shruti Chaturvedi is an Associate Professor of Medicine at Johns Hopkins. She received her medical degree from Maulana Azad Medical College, University of Delhi, India. She then completed a residency in Internal Medicine at the Cleveland Clinic, Cleveland, OH, and a fellowship in Hematology and Oncology at Vanderbilt University, Nashville, TN. She has additionally obtained a Master of Science in Clinical Investigation (MSCI) degree from Vanderbilt University. Dr. Chaturvedi specializes in the care of adults with non-malignant hematologic disorders including thrombocytopenic purpura, atypical hemolytic uremic syndrome, antiphospholpiid syndrome, immune thrombocytopenia, autoimmune hemolytic anemia, thrombotic, other bleeding and clotting disorders, and anemias. Her research is focused on improving the care of patients with thrombotic microangiopathies with a focus on long term sequelae, and the role of complement in thrombotic disorders such as the antiphospholipid syndrome. Dr. Chaturvedi is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Blood Clots, Atypical Hemolytic Uremic Syndrome (aHUS), Anemia, Splenectomy, and Bone Marrow Aspiration.

Sarah Khan is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Venous Thromboembolism (VTE), Pulmonary Hypertension, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA. Dr. Pavlovich grew up in Washington DC, went to Harvard University, and then earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He then completed a urology residency at New York Hospital-Cornell Medical Center and a National Cancer Institute SUO fellowship in urologic oncology before joining the Hopkins faculty in 2001. Dr. Pavlovich has published over 150 peer-reviewed articles, is Associate Editor of The Prostate and is on the Editorial Board of the British Journal of Urology International. He was the inaugural Director of the Brady Urological Institute’s SUO Urologic Oncology Fellowship (2014 -2024) and is the recipient of three “best teaching/research mentor” awards from the Urology residents at Johns Hopkins. Dr. Pavlovich speaks English, French, Spanish, German, and Serbo-Croatian. He enjoys spending time with his wife and children, following their pursuits, and skiing, diving, running, wildlife, and the great outdoors. Dr. Pavlovich is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

Dr. Hicks specializes in congenital aortic pathologies including aberrant subclavian arteries and aortic coarctation, thoracic and abdominal aortic aneurysms, complex lower extremity revascularization including lower extremity bypasses and stenting, and carotid endarterectomy. She is skilled in both open and endovascular surgery for the treatment of aortic and peripheral disease. She is also accomplished in clinical research with over 130 peer-reviewed publications and numerous textbook chapters; her research interests include clinical outcomes in aneurysm repair and lower extremity revascularization, as well as high-value care in vascular surgery. A distinguished fellow of the American Board of Surgery, Dr. Hicks is the recipient of the Department of Surgery Rothman Early Career Development Award for Surgical Research and was selected as a Visiting Scholar to the American Board of Medical Specialties for 2018-2019. She is also an appointed member of a CMS Clinical Expert Subcommittee tasked with refining peripheral vascular disease cost measures for implementation in the Quality Payment Program. LinkedIn https://www.linkedin.com/in/caitlin-hicks-b211b617/. Dr. Hicks is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Carotid Artery Disease, Peripheral Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement.

Adam Levin, MD, joined the Johns Hopkins Department of Orthopaedic Surgery as an assistant professor in orthopaedic oncology. Dr. Levin comes to Johns Hopkins after working as an orthopaedic oncologist at the North Shore/LIJ Health System in New York. He completed his residency in orthopaedic surgery at Long Island Jewish Medical Center, and a fellowship in orthopaedic oncology at the Memorial Sloan-Kettering Cancer Center. Dr. Levin offers care and consultations for adults and children with bone and soft tissue tumors of the pelvis and extremities. He has extensive experience in performing limb-sparing and complex extremity reconstruction surgeries. Dr. Levin has a special interest in surgical palliation and biologic reconstruction. Dr. Levin is a member of the American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society. Dr. Levin is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Adult Soft Tissue Sarcoma, Osteosarcoma, Ollier Disease, Hip Replacement, and Osteotomy.

Dr. Allen Everett is a professor of pediatrics at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general pediatric cardiology. Dr. Everett earned his M.D. from East Tennessee State University. He completed his residency in pediatrics and fellowship in pediatric cardiology at the University of Virginia. Dr. Everett joined the Johns Hopkins faculty in 2003. He has become the program leader at Johns Hopkins in pediatric biomarker discovery, with a particular focus on brain injury, pulmonary hypertension and effects of medical plastics exposure on congenital heart disease outcomes. He is the principal investigator (PI) or co-PI on multiple NIH- funded R01 studies. Dr. Everett also serves as the director of the Pediatric Proteome Center. Dr. Everett is an author of over 140 peer review papers, three book chapters, editor/author of the Illustrated Field Guide to Congenital Heart Disease and Repair, now in its fourth edition, and senior associate editor for the journal, Cardiology in the Young. He is a co-developer of PedCathTM cardiac catheterization software with Scientific Software Solutions which has been translated into five languages, has five US biomarker patents filed and brain injury biomarkers licensed to ImmunArray, Ltd. Dr. Everett is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Hypertension, Pulmonary Hypertension, Congenital Heart Disease (CHD), Heart Bypass Surgery, and Heart Transplant.

Dr. Gedge Rosson is an associate professor of plastic and reconstructive surgery and oncology at the Johns Hopkins University School of Medicine. He specializes in complex peripheral nerve surgery and microvascular perforator flap breast reconstructions, such as the DIEP (deep inferior epigastric artery perforator flap), the SIEA (superficial inferior epigastric artery flap), the SGAP (superior gluteal artery perforator flap), the TUG (transverse upper gracilis flap) and the PAP (Profunda Artery Perforator flap). He was the first surgeon in the United States to widely implement pre-operative mapping of the abdominal perforators using 64-slice multidetector 3-D CT scan angiograms, and he is one of the first to now regularly connect nerves to improve breast reconstruction. Dr. Rosson serves as the director of breast reconstruction and Microsurgery Fellowship program director. He is also chair of the Compliance Committee of the Office of Johns Hopkins Physicians, chair of the Risk Management Committee of the Johns Hopkins Hospital and chair of the Special Credentialing Review Committee of Johns Hopkins Health Care. He graduated from New York Medical College in 1998 after receiving his undergraduate degree from the University of California, Berkeley. He did his internship and general surgery and plastic surgery residency training at The Johns Hopkins Hospital/University of Maryland combined program. Dr. Rosson then completed a peripheral nerve surgery fellowship at the Dellon Institute for Peripheral Nerve Surgery in Baltimore, Maryland. His research interests include patient safety and outcomes studies in microsurgery, breast reconstruction and peripheral nerve surgery as well as tissue engineering. His research has been published in major peer-reviewed scientific journals and presented at both national and international meetings. Dr. Rosson currently has hospital privileges at The Johns Hopkins Hospital, the R. Adams Cowley Shock-Trauma Center and Greater Baltimore Medical Center (GBMC) in Baltimore, Maryland. Dr. Rosson is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Carpal Tunnel Syndrome, Breast Enlargement In Males, Venous Thromboembolism (VTE), Facial Paralysis, and Lymphadenectomy.

Sbaa Syeda, M.D., is an assistant professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine in Baltimore. Her areas of clinical expertise include obstetrics and maternal-fetal medicine. Dr. Syeda obtained her medical degree from Johns Hopkins. She completed a residency in gynecology and obstetrics and a fellowship in maternal-fetal medicine at the Columbia University Irving Medical Center in New York. Sbaa Syeda is involved in research regarding equality in care. Her clinical interests include management of complex maternal medical conditions, spanning from preconception to postpartum conditions; prenatal diagnosis of fetal conditions and ultrasound-guided procedures. Dr. Syeda is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are HELLP Syndrome, Venous Thromboembolism (VTE), Preeclampsia, and Hysterectomy.

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), and Discoid Lupus Erythematosus (DLE).

Dr. Anum Minhas attended medical school at Duke University and trained in internal medicine at the University of Michigan, Ann Arbor. During her Cardiology fellowship training at Johns Hopkins University School of Medicine, she served as the Chief Cardiology fellow and was honored to receive the Marie-Josee and Henry R. Kravis Endowed Fellowship and the Lou and Nancy Grasmick Endowed Research Fellowship (2021-2022). She was also awarded the Dlabal Clinical Research award for originality and creativity in research. During her fellowship, she completed additional training and obtained a Master of Health Science with focus in cardiovascular epidemiology as an NIH T32 postdoctoral fellow at the Johns Hopkins Bloomberg School of Public Health. She also completed additional clinical training during fellowship in Advanced Echocardiography, and designed and completed an inaugural fellowship in Cardio-Obstetrics. Dr. Minhas joined the Johns Hopkins Cardiology faculty with a clinical focus in women's cardiovascular health, specifically Cardio-Obstetrics, or cardiac disease around pregnancy. She also attends in the coronary critical care unit and the echocardiography laboratory. She was selected as a recipient of an NIH-sponsored KL2 award through the Clinical Research Scholars Program. Her current research focuses on preventing and managing cardiovascular disease associated with pregnancy complications, such as preeclampsia. She is the recipient of several grants and has coauthored multiple publications and book chapters in women's cardiovascular health. She hopes to use her research to raise awareness of and provide insights into mechanisms of pregnancy-associated cardiac disease and promote health equity in maternal health. Videos Community ConversationMaternal Health Recent News Articles and Media Coverage https://the1a.org/segments/in-good-health-unpacking-heart-disease-in-women/ In Good Health: Medical missteps for women with heart disease, NPR Podcast. Dr. Minhas is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Peripartum Cardiomyopathy, Pulmonary Edema, COVID-19, and Cardiomyopathy.

Thorsten Leucker is a Cardiologist in Baltimore, Maryland. Dr. Leucker is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Apoplexy, Heart Attack, Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH).

Brock Lindsey, M.D., is an orthopaedic surgeon specializing in orthopaedic oncology. He treats children and adults with all types of bone and soft tissue sarcomas. Dr. Lindsey has expertise in nanoparticle delivery of immunotherapy, immunodiagnostics as a novel treatment for osteosarcoma, as well as complex reconstruction after amputation, including osseointegration. Dr. Lindsey earned his medical degree from the University of Cincinnati. He then completed an orthopaedic surgery residency at West Virginia University’s (WVU) J.W. Ruby Memorial Hospital, becoming the department’s first to complete a research fellowship during residency. Dr. Lindsey also pursued a fellowship in musculoskeletal oncology at the University of Pittsburgh Medical Center (UPMC) and UPMC Children’s Hospital before returning to WVU Medicine as an attending physician. During his 12 years at WVU Medicine, Dr. Lindsey created programs in musculoskeletal oncology and adult reconstruction as well as a multidisciplinary amputation clinic. He also led a musculoskeletal research laboratory into the national rankings for federal funding for orthopaedic surgery departments. His research focuses on improving treatment strategies for metastatic osteosarcoma and exploring human/machine interfaces for amputees. His work has been published in local, national and international basic science and clinical research journals. Dr. Lindsey has experience mentoring and training students at all levels from undergraduate and graduate students to postdoctoral positions. He won Press Ganey’s “Top Provider” award every year between 2013 and 2018. He also founded ICaPath, a biotech startup derived from his laboratory research that is currently working toward a first in-human clinical trial. Videos Brock Lindsey, M.D.Orthopaedic Oncologist OsseointegrationQ&A with Dr. Brock Lindsey. Dr. Lindsey is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Bone Tumor, Adult Soft Tissue Sarcoma, Osteosarcoma, Leg or Foot Amputation, and Hip Replacement.

Dr. Babar Shafiq is an orthopaedic surgeon fellowship trained in traumatology who performs surgery for acute trauma and adult reconstruction. As an Associate Professor of Orthopaedic Surgery at the Johns Hopkins University School of Medicine, the Johns Hopkins Hospital and Johns Hopkins Howard County Medical Center. Dr. Shafiq is very active clinically caring for patients with a broad range of orthopaedic injuries and conditions. An abbreviated list incudes: Poorly healing Fractures called Non-unions/Malunions Limb Deformity/Limb Length Hip Replacements Fractures: Lower Extremity: Hip, Pelvis, Acetabulum, Femur, Tibia, Tibia plateau, Ankle, Foot Upper Extremity: Shoulder, Clavicle, Humerus, Scapula, Elbow, Forearm, Distal Radius Fractures around hip and knee replacements Dr. Shafiq completed his orthopaedic trauma fellowship in Minnesota at the renowned Regions Hospital/University of Minnesota - Twin Cities Orthopaedic Trauma Fellowship. He has practiced orthopaedic traumatology at the Johns Hopkins Hospital since 2013 after spending 2 years serving as the Director of Orthopaedic Trauma at Howard University Hospital where he also completed his medical and residency training. In addition, Dr. Shafiq formerly practiced Physical Therapy after completing a master's degree prior to attending medical school. His knowledge of biomechanics, rehabilitation, and surgery make him uniquely qualified to guide patients from injury through rehab and on to optimal recovery. Current academic and administrative appointments: Director: Johns Hopkins Orthopaedic Bone Health Center (where he partners with Andra Love, PA-C to identify and manage the care of patients with fragility fractures and osteoporosis related fracture risk) Associate Program Director: Johns Hopkins Orthopaedic Residency training program Dr. Shafiq is very active in teaching and research. He gives lectures and teaches medical students, residents and fellows on a daily basis both at Johns Hopkins and at regional, national and international courses. Dr. Shafiq has authored or co-authored over 70 peer-reviewed publications and book chapters (See PUBMED for a detailed list) Outside of the hospital Dr. Shafiq spends time with his wife, 3 children and his dog. He is active in cycling, running and swimming. Dr. Shafiq is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Compartment Syndrome, Infectious Arthritis, Axillary Nerve Dysfunction, Fasciotomy, and Hip Replacement.

"Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins. He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke. Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983. A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine. Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander ""Buck"" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.". Dr. Casella is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Dr. Ali Bydon is a renowned neurosurgeon and director of the Division of Spine Surgery and the Neurosurgical Spine Center at the Johns Hopkins University School of Medicine. As the endowed Ziya Gokaslan Professor of Neurosurgery, he is dedicated to advancing the field through innovative clinical practices and extensive research. Additionally, Dr. Bydon serves as the vice chair for strategic planning within the Department of Neurosurgery. Dr. Bydon’s clinical practice is centered on degenerative disorders of the spine, spinal tumors, spinal trauma and complex spinal reconstruction. He is an esteemed member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. Dr. Bydon earned his medical degree from the University of Michigan School of Medicine in 1999 and completed his residency in neurological surgery at Henry Ford Hospital in Detroit, where he graduated with distinction in 2006. He further honed his skillset by completing fellowships in minimally invasive spine surgery and the surgical treatment of peripheral nerves, followed by a one-year instructorship in spinal oncology and complex reconstructive spinal surgery at Johns Hopkins in 2007. His research focuses on spinal biomechanics and surgical outcomes. He has co-authored over 265 peer-reviewed manuscripts and numerous book chapters. Dr. Bydon has made significant contributions to the understanding of optimal surgical management for conditions such as spinal synovial cysts, cervical myelopathy, lumbar spondylolisthesis, ossified posterior longitudinal ligament, cervical degenerative disorders, cervical myelopathy, thoracic myelopathy and metastatic diseases to the spine, among others. Dr. Bydon has presented at more than 200 national and international scientific meetings, underscoring his commitment to advancing knowledge in the field. An educator who has trained over 75 practicing neurosurgeons, Dr. Bydon has received prestigious accolades, including the Richard Otenasak Faculty Teaching Award and the Chairman’s Neurosurgical Teacher of the Year Award. His leadership roles have included serving on the residency review committee and the patient access committee at Johns Hopkins, as well as a yearlong term as the neurosurgical representative on the Johns Hopkins Faculty Senate. He has also served as a medical director with Johns Hopkins Medicine International, overseeing clinical and educational activities at renowned institutions in Lebanon and Brazil. Dr. Bydon has performed more than 5,000 surgeries. His commitment to excellence in patient care, education and research makes him a leading authority in spine surgery, dedicated to providing transformative care to patients seeking relief and recovery. Dr. Bydon is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Spinal Stenosis, Spondylolisthesis, Invertebral Disc Disease, Laminectomy, and Spinal Fusion.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant.

Peter A. Najjar, M.D., M.B.A., is a surgeon with specialization in colon and rectal surgery. He earned his medical degree from the University of Chicago and completed his surgical residency and colorectal fellowship at Harvard's Brigham and Women’s Hospital/Dana-Farber Cancer Institute in Boston. He offers advanced colorectal care including robotic and laparoscopic approaches for benign and malignant disease. In addition to his clinical experience, Dr. Najjar received a Master of Business Administration from Harvard Business School and completed the Harvard Medical School Fellowship in Quality and Patient Safety. He works with the health system to protect patients from harm, improve their outcomes and experiences, and eliminate disparities. Dr. Najjar’s research focuses on making care safe, affordable, and patient-centered from the clinic to the operating room. Dr. Najjar is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Familial Colorectal Cancer, Anal Cancer, Anorectal Abscess, Ileostomy, and Fasciotomy.